IBAB Ion Beam Applications SA

IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day

IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day



Louvain-la-Neuve, Belgium, 04 April, 2025 –  (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will be hosting a Capital Markets Day (CMD) this coming Monday 7 April from 2pm to 5:00pm CEST (8am ET to 11:00am ET) at its headquarters in Louvain-la-Neuve, Belgium, and via live webcast.

At the event IBA’s management team will outline the company’s strategic roadmap and long-term growth ambitions. The agenda is outlined below:

  • Webcast open: 2pm
  • Purpose, Vision & Strategy​​
  • Business Review – Execution Plan & Opportunities​​
    • Industrial Solutions
    • RadioPharma Solutions
    • Engineering & Supply Chain
    • Proton Therapy
    • Dosimetry
    • New Ventures
  • Financials & Outlook
  • Webcast close: 5pm

To attend via webcast, register via this . Please complete the registration at least 15 minutes before the start of the event. No new material financial information will be delivered during the CMD.

The presentation will be made available on IBA’s website ahead of the event on and a recording will also be made available shortly afterwards on the same page and on .

For further information, please contact ICR Healthcare at .   

***ENDS***

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as the most advanced form of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,100 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at:

CONTACTS

Olivier Lechien

Corporate Communication Director



ICR Healthcare

Amber Fennell, Angela Gray, Lucy Featherstone

+44 (0) 20 3709 5700

Attachment



EN
04/04/2025

Underlying

IBABIon Beam Applications SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA to share long-term growth strategy at upcoming 2025 Capital Market...

IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day Louvain-la-Neuve, Belgium, 04 April, 2025 –  (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will be hosting a Capital Markets Day (CMD) this coming Monday 7 April from 2pm to 5:00pm CEST (8am ET to 11:00am ET) at its headquarters in Louvain-la-Neuve, Belgium, and via live webcast. At the event IBA’s management team will outline the company’s strategic roadmap and long-term growth ambitions. The agenda is outlined below: Webcast open: 2pmPurpose, Vision & Strategy​​Bu...

18h / 14m 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA présente sa stratégie de croissance à long terme lors de son Capit...

IBA présente sa stratégie de croissance à long terme lors de son Capital Markets Day 2025 Louvain-la-Neuve, Belgique, le 4 avril 2025 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules, organise un Capital Markets Day (CMD-journée investisseurs) ce lundi 7 avril de 14h à 17h00 heure de Bruxelles (8h à 11h00 heure de Washington) à son siège à Louvain-la-Neuve et via un webcast. Lors de cet événement, la direction de la société présentera la feuille de route stratégique de l'entreprise et ses ambitions de croissance à long terme. L...

18h / 14m 1 EN
ING Helpdesk
  • ING Helpdesk
COLR Etablissementen...
DIE D'IETEREN SA ... (+4)

Benelux Morning Notes

Ackermans & van Haaren: Banks & Batteries. Colruyt: New acquisition in eCommerce. D'Ieteren: March car registrations down 10%, VW down 13%. IBA: IBA to supply P1 system to Tri-Service General Hospital in Taiwan

COLR ETABLISSEMENTEN FRANZ COLRUYT N.V.
DIE D'IETEREN SA
IBAB ION BEAM APPLICATIONS SA
ACKB ACKERMANS & VAN HAAREN NV
04/02/25 April 2, 2025 1 EN
Guy Sips ... (+7)
  • Guy Sips
  • Jacob Mekhael
  • Lynn Hautekeete
  • Michiel Declercq
  • Sharad Kumar S.P
  • Thomas Couvreur
  • Wim Hoste
COLR Etablissementen...
TERB TER BEKE N.V. ... (+10)

Morning Notes : ACKB BB, AGFB BB, COLR BB, IBAB BB, IVA FP, ONTEX BB, ...

: ACKB BB, AGFB BB, COLR BB, IBAB BB, IVA FP, ONTEX BB, WHATS BB, SHUR BB, EKOP BB, ARG FP

COLR ETABLISSEMENTEN FRANZ COLRUYT N.V.
TERB TER BEKE N.V.
AGFB AGFA-GEVAERT NV
IBAB ION BEAM APPLICATIONS SA
ACKB ACKERMANS & VAN HAAREN NV
ONTEX ONTEX GROUP N.V.
ARG ARGAN SA
IVA INVENTIVA SA
EKOP EKOPAK NV
SHUR SHURGARD SELF STORAGE LIMITED
04/02/25 April 2, 2025 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA signs contract for a Proteus®ONE solution to be installed at the T...

IBA signs contract for a Proteus®ONE solution to be installed at the Tri-Service General Hospital in Taiwan Louvain-La-Neuve, Belgium, April 2nd, 2025 – (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the supply of a Proteus®ONE1 compact proton therapy solution to be located at the Tri-Service General Hospital in Taipei, Taiwan. The contract includes the supply of a Proteus®ONE system and a Quality Assurance...

April 2, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch